25,600 results
Previously, MKM Partners Initiated LLY at to Sell. The average price target for LLY shares by the analysts covering the stock is $56.24, which is 10.58% above where the stock opened this morning. Eli Lilly and Company …Jutia Group · 2 hours ago
nextiphonenews.com
[at Wall St. Cheat Sheet] – After failing to meet the company’s primary goals for the drug during three late-stage trials, Eli Lilly will cease the development of edivoxetine. Read more on this. Eli Lilly and Company (LLY) …Jutia Group · 12/6/2013
In-depth coverageJ.C. Penney (JCP) is having a store wide 50% off sale, but unfortunately it’s on the value of its stock. A favorite of short sellers, this retailer is struggling in the face of an economy that has been especially tough on stores that cater to ...Investor Place · 8 hours ago
More from Bing News
Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Trade-Ideas LLC identified Eli Lilly and Company (LLY ...TheStreet.com · 10/23/2013
At Stock Options Channel, our YieldBoost formula has looked up and down the LLY options chain for the new July 2014 contracts and identified one put and one call contract of particular interest. The put contract at the $45.00 strike price has a ...Forbes · 11/18/2013
Investors in Eli Lilly & Co. (NYSE: LLY) saw new options become available today, for the September 6th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the LLY options chain for the new September 6th contracts ...Forbes · 8/29/2013
Costco (COST), Eli Lilly (LLY), Royal Dutch Shell (RDS) and Walmart (WMT) were among some of the widely held stocks upgraded by Louis Navellier in his latest fundamental stock analysis on April 12, 2010. Pharmaceutical stock Eli Lilly (LLY) has been ...Investor Place · 4/12/2010
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Trade-Ideas LLC identified Eli Lilly and ...TheStreet.com · 9/26/2013
Eli Lilly (LLY) stock fell more than 2% in early trading in the stock market Thursday after its drug candidate ramucirumab failed a breast-cancer trial, though it succeeded in stomach cancer. The late-stage trials looked at the key metrics of progression ...Investors Business Daily · ByAmy Reeves · 9/26/2013
New York, NY -- (SBWIRE) -- 11/27/2013 -- Growing Stock Report expands its NYSE Decliners Weekly Watch List adding Eli Lilly and Company (NYSE:LLY) and Eldorado Gold Corp. (NYSE:EGO). Eli Lilly and Company (NYSE:LLY) a company that …SBWire · 11/27/2013
- © 2013 Microsoft |
- Privacy and Cookies |
- Legal |
- Advertise |
- About our ads |
- Help |
- Feedback